Apellis Pharmaceuticals
APLS
#3526
Rank
A$4.55 B
Marketcap
$36.30
Share price
-2.09%
Change (1 day)
-58.13%
Change (1 year)

EPS for Apellis Pharmaceuticals (APLS)

EPS in 2023 (TTM): -$7.89

According to Apellis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$8.46. In 2022 the company made an earnings per share (EPS) of -$9.88 an increase over its 2021 EPS that were of -$14.26.

EPS history for Apellis Pharmaceuticals from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.89-20.17%
2022-$9.88-30.73%
2021-$14.2692.81%
2020-$7.40-11.73%
2019-$8.38123.18%
2018-$3.7627.08%
2017-$2.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.51-58.48%๐Ÿ‡บ๐Ÿ‡ธ USA